David A Bereiter
Overview
Explore the profile of David A Bereiter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
758
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Katagiri A, Kishimoto S, Okamoto Y, Yamada M, Niwa H, Bereiter D, et al.
Sleep
. 2024 Jan;
47(3).
PMID: 38166171
Study Objectives: Obstructive sleep apnea, a significant hypoxic condition, may exacerbate several orofacial pain conditions. The study aims to define the involvement of calcitonin gene-related peptide (CGRP) in peripheral and...
2.
Tashiro A, Bereiter D, Ohta H, Kawauchi S, Sato S, Morimoto Y
J Neurotrauma
. 2023 Dec;
41(7-8):985-999.
PMID: 38115600
Mild traumatic brain injury (mTBI) is often accompanied by neurological and ocular symptoms that involve trigeminal nerve pathways. Laser-induced shock wave (LISW) was applied to the skull of male rats...
3.
Katagiri A, Tsubota K, Mikuzuki L, Nakamura S, Toyofuku A, Kato T, et al.
Neurosci Res
. 2023 Jan;
191:66-76.
PMID: 36657726
The P2Y receptor agonist, diquafosol sodium, is commonly used to treat the signs and symptoms of dry eye disease (DE) patients. Although diquafosol improves tear film stability, the neural mechanisms...
4.
Katagiri A, Tsubota K, Mikuzuki L, Nakamura S, Toyofuku A, Kato T, et al.
Neurosci Lett
. 2022 Nov;
792:136939.
PMID: 36341926
Patients with persistent and severe dry eye disease (DED) have corneal hypersensitivity, resulting in ocular pain, and diquafosol sodium, a potent P2Y receptor agonist, is commonly used to improve the...
5.
Peck C, Bereiter D, Eberly L, Lenglet C, Moana-Filho E
PLoS One
. 2022 Oct;
17(10):e0266349.
PMID: 36240243
High-impact temporomandibular disorder (TMD) pain may involve brain mechanisms related to maladaptive central pain modulation. We investigated brain responses to stimulation of trigeminal sites not typically associated with TMD pain...
6.
Bereiter D, Rahman M, Ahmed F, Thompson R, Luong N, Olson J
Front Pharmacol
. 2022 Apr;
13:827244.
PMID: 35479310
Dry eye disease (DED) is recognized as a chronic inflammatory condition with an increase in tear osmolarity and loss of tear film integrity. DED is often accompanied by adverse ocular...
7.
Ahmed F, Rahman M, Thompson R, Bereiter D
Front Pain Res (Lausanne)
. 2022 Mar;
2:715871.
PMID: 35295418
Temporomandibular joint disorders (TMD) consist of a heterogeneous group of conditions that present with pain in the temporomandibular joint (TMJ) region and muscles of mastication. This project assessed the role...
8.
Herrero Babiloni A, Exposto F, Peck C, Lindgren B, Martel M, Lenglet C, et al.
Sci Rep
. 2022 Feb;
12(1):1657.
PMID: 35102207
Temporomandibular disorders (TMD) patients can present clinically significant jaw pain fluctuations which can be debilitating and lead to poor global health. The Graded Chronic Pain Scale evaluates pain-related disability and...
9.
Kishimoto S, Katagiri A, Oyamaguchi A, Sato H, Toyoda H, Niwa H, et al.
Neuroscience
. 2021 Dec;
483:66-81.
PMID: 34883200
Obstructive sleep apnea (OSA), characterized by low arterial oxygen saturation during sleep, is associated with an increased risk of orofacial pain. In this study, we simulated chronic intermittent hypoxia (CIH)...
10.
The effects of estrogen on temporomandibular joint pain as influenced by trigeminal caudalis neurons
Tashiro A, Bereiter D
J Oral Sci
. 2020 Mar;
62(2):150-155.
PMID: 32132330
The signs and symptoms of persistent temporomandibular joint (TMJ)/muscle disorder (TMJD) pain suggest the existence of a central neural dysfunction or a problem of pain amplification. The etiology of chronic...